Form D · Other
Act & Acre, Inc.
New York, NY · CIK 0001759749
Offering snapshot reported May 6, 2021 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 21, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 6, 2021 | Initial | $7,001,707 | No comparison | 2 | SEC filing |
| Nov 26, 2018 | Initial | $2,999,999 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398522
The Total Offering Amount and the Total Amount Sold includes the conversion of $201,709.59 of outstanding convertible securities.
Source: Form D, filed May 6, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rachel Conlan | Director |
| Steven Leistner | Director |
| Colm Patrick Mackin | Director, Executive |
| Helen Reavey | Director, Executive |
| Sarah A. Woelfel | Director |
Issuer details
Industry: Other (See others in industry)
Address:
10 Park Avenue, 16 K
New York, NY, 10016
New York, NY, 10016